Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Immunogenicity of Adjuvanted Versus High-Dose Inactivated Influenza Vaccines in Older Adults

NCT03183908 is registered in ClinicalTrials.gov with Duke University as lead sponsor.

NCT NCT03183908
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03183908 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Immunogenicity of Adjuvanted Versus High-Dose Inactivated Influenza Vaccines in Older Adults
Lead sponsor
Duke University
Phase
Phase 4
Overall status
Completed
Start date
August 28, 2017
Completion date
February 14, 2019
Enrollment
757 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

adverse drug event, injection site reaction, pain, quality of life, side effect of drug